None of them showed an isolated anti-HBc pattern, and HBV DNA testing was not performed, as there were no clinical indications or risk factors suggesting occult hepatitis B. It is worth noting that active HBV infection represents a contraindication for CAB + RPV LA due to the risk of viral reactivation, but none of the patients met this criterion. This evidence concerns the gene KRT88P and hepatitis B virus infection.